ReviewJSES reviews, reports, and techniques2025
Stemless reverse total shoulder arthroplasty: a systematic review and meta-analysis.
Review in JSES reviews, reports, and techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Complication rates following total shoulder arthroplasty for osteoarthritis versus proximal humerus fracture: a propensity-matched cohort comparison of 9,190 patients.Journal of shoulder and elbow arthroplasty · 2026Article
- Pilot biomechanical study of complex upper-limb movements in patients with RSA using inertial sensors: Feasibility of sport-specific gestures.Shoulder & elbow · 2026Article
- Stemless shoulder arthroplasty: what are the benefits?JSES reviews, reports, and techniques · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stemless reverse total shoulder arthroplasty (rTSA) is one of the many modifications of the original Grammont rTSA design. Much has been made of the debate between stemless and stemmed humeral implants for anatomic reverse shoulder arthroplasty, with less attention awarded to the relatively newer variation in stemless rTSA. Proposed advantages of said design include preserving bone stock, ease of revision, reduced blood loss, and shortening surgical times. Methods: A systematic search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines using search engines in PubMed, EMBASE, and Cochrane to retrieve all relevant studies. Results: Initial search strategies produced 174 studies, of which 15 studies were included for full analysis in this review. This included 657 shoulders in 648 patients (9 bilateral cases). Stemless rTSA led to significant improvement in functional outcomes and range of motion (ROM) across all studies. Meta-analysis of comparative studies including stemless and stemmed rTSA showed no significant difference in ROM measurements across abduction (standardized mean difference [SMD] -0.17, 95% confidence interval [CI]: -1.05, 0.70) or forward flexion (SMD -0.36, 95% CI: -1.23, 0.50). However, there was a statistically significant difference in internal rotation in favor of stemless implants (SMD -0.79, 95% CI: -1.56, -0.03). There was no significant difference in visual analog scale (VAS) between stemmed and stemless designs (SMD -0.31, 95% CI: -2.32, 1.69). Likewise, there was no significant difference in odds ratio (OR) for revision rates (OR: 1.02, 95% CI: 0.92, 1.14) or overall complications (OR: 0.82, 95% CI: 0.2, 3.42). Across all 15 studies, comparative and noncomparative studies, overall complication rates for stemless rTSA stood at 13.4% and revision rates at 5.5%. Conclusion: Stemless rTSA achieves similar functional outcomes to stemmed rTSA designs. Stemless designs achieved superior internal rotation in the comparative studies. Proposed advantages of stemless rTSA including reduced blood loss and lesser surgical times need further research, as does the long-term robustness of this relatively novel design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.